133 related articles for article (PubMed ID: 26035713)
21. Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS).
Lacey A; Hedrick E; Li X; Patel K; Doddapaneni R; Singh M; Safe S
Oncotarget; 2016 May; 7(21):31257-69. PubMed ID: 27144436
[TBL] [Abstract][Full Text] [Related]
22. NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.
Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
Mol Cell Biol; 2016 May; 36(9):1383-94. PubMed ID: 26929200
[TBL] [Abstract][Full Text] [Related]
23. Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.
Hedrick E; Li X; Cheng Y; Lacey A; Mohankumar K; Zarei M; Safe S
Breast Cancer Res Treat; 2019 Aug; 177(1):29-40. PubMed ID: 31119568
[TBL] [Abstract][Full Text] [Related]
24. Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?
Bidooki SH; Navarro MA; Fernandes SCM; Osada J
Curr Issues Mol Biol; 2024 Apr; 46(4):3134-3163. PubMed ID: 38666927
[TBL] [Abstract][Full Text] [Related]
25. Oxygen-Glucose Deprivation Increases NR4A1 Expression and Promotes Its Extranuclear Translocation in Mouse Astrocytes.
Moriyama K; Horino A; Kohyama K; Nishito Y; Morio T; Sakuma H
Brain Sci; 2024 Feb; 14(3):. PubMed ID: 38539632
[TBL] [Abstract][Full Text] [Related]
26. Natural products and synthetic analogs as selective orphan nuclear receptor 4A (NR4A) modulators.
Safe S
Histol Histopathol; 2024 May; 39(5):543-556. PubMed ID: 38116863
[TBL] [Abstract][Full Text] [Related]
27. Piperlongumine is a ligand for the orphan nuclear receptor 4A1 (NR4A1).
Zhang L; Martin G; Mohankumar K; Wright GA; Mariyam F; Safe S
Front Pharmacol; 2023; 14():1223153. PubMed ID: 37808182
[TBL] [Abstract][Full Text] [Related]
28. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.
Burris TP; de Vera IMS; Cote I; Flaveny CA; Wanninayake US; Chatterjee A; Walker JK; Steinauer N; Zhang J; Coons LA; Korach KS; Cain DW; Hollenberg AN; Webb P; Forrest D; Jetten AM; Edwards DP; Grimm SL; Hartig S; Lange CA; Richer JK; Sartorius CA; Tetel M; Billon C; Elgendy B; Hegazy L; Griffett K; Peinetti N; Burnstein KL; Hughes TS; Sitaula S; Stayrook KR; Culver A; Murray MH; Finck BN; Cidlowski JA
Pharmacol Rev; 2023 Nov; 75(6):1233-1318. PubMed ID: 37586884
[TBL] [Abstract][Full Text] [Related]
29. The role and mechanism of TXNDC5 in diseases.
Wang X; Li H; Chang X
Eur J Med Res; 2022 Aug; 27(1):145. PubMed ID: 35934705
[TBL] [Abstract][Full Text] [Related]
30. Plant Alkaloid Tetrandrine Is a Nuclear Receptor 4A1 Antagonist and Inhibits Panc-1 Cell Growth In Vitro and In Vivo.
Lee HS; Kim DH; Lee IS; Park JH; Martin G; Safe S; Kim KJ; Kim JH; Jang BI; Lee SO
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563670
[TBL] [Abstract][Full Text] [Related]
31. Thioredoxin Domain Containing 5 Suppression Elicits Serum Amyloid A-Containing High-Density Lipoproteins.
Sánchez-Marco J; Martínez-Beamonte R; Diego A; Herrero-Continente T; Barranquero C; Arnal C; Surra J; Navarro MA; Osada J
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327511
[TBL] [Abstract][Full Text] [Related]
32. Flavonoids kaempferol and quercetin are nuclear receptor 4A1 (NR4A1, Nur77) ligands and inhibit rhabdomyosarcoma cell and tumor growth.
Shrestha R; Mohankumar K; Martin G; Hailemariam A; Lee SO; Jin UH; Burghardt R; Safe S
J Exp Clin Cancer Res; 2021 Dec; 40(1):392. PubMed ID: 34906197
[TBL] [Abstract][Full Text] [Related]
33. NR4A1 Ligands as Potent Inhibitors of Breast Cancer Cell and Tumor Growth.
Karki K; Mohankumar K; Schoeller A; Martin G; Shrestha R; Safe S
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072371
[TBL] [Abstract][Full Text] [Related]
34. Broussochalcone A Is a Novel Inhibitor of the Orphan Nuclear Receptor NR4A1 and Induces Apoptosis in Pancreatic Cancer Cells.
Lee HS; Kim SH; Kim BM; Safe S; Lee SO
Molecules; 2021 Apr; 26(8):. PubMed ID: 33923503
[TBL] [Abstract][Full Text] [Related]
35. The nuclear receptor 4A family members: mediators in human disease and autophagy.
Chen L; Fan F; Wu L; Zhao Y
Cell Mol Biol Lett; 2020 Nov; 25(1):48. PubMed ID: 33292165
[TBL] [Abstract][Full Text] [Related]
36. The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies.
Jaganjac M; Milkovic L; Sunjic SB; Zarkovic N
Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33228209
[TBL] [Abstract][Full Text] [Related]
37. The Paradoxical Roles of Orphan Nuclear Receptor 4A (NR4A) in Cancer.
Safe S; Karki K
Mol Cancer Res; 2021 Feb; 19(2):180-191. PubMed ID: 33106376
[TBL] [Abstract][Full Text] [Related]
38. Bis-indole derived nuclear receptor 4A1 (NR4A1) antagonists inhibit TGFβ-induced invasion of embryonal rhabdomyosarcoma cells.
Shrestha R; Mohankumar K; Safe S
Am J Cancer Res; 2020; 10(8):2495-2509. PubMed ID: 32905449
[TBL] [Abstract][Full Text] [Related]
39. A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity.
Karki K; Wright GA; Mohankumar K; Jin UH; Zhang XH; Safe S
Cancer Res; 2020 Mar; 80(5):1011-1023. PubMed ID: 31911554
[TBL] [Abstract][Full Text] [Related]
40. Function of Nr4a Orphan Nuclear Receptors in Proliferation, Apoptosis and Fuel Utilization Across Tissues.
Herring JA; Elison WS; Tessem JS
Cells; 2019 Nov; 8(11):. PubMed ID: 31683815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
